BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sánchez-Ramón S, Dhalla F, Chapel H. Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. Front Immunol 2016;7:317. [PMID: 27597852 DOI: 10.3389/fimmu.2016.00317] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Hassan H, Ammad Ud Din M, Jamshed S, Bress J, Mustafa SS. Effect of Ibrutinib on Hmphocytic Leukemia: a Single-Center Experience. Hematol Oncol Stem Cell Ther 2022;15:208-12. [PMID: 34391729 DOI: 10.1016/j.hemonc.2021.07.004] [Reference Citation Analysis]
2 Sim B, Ng JY, Teh BW, Talaulikar D. Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule. Leukemia & Lymphoma 2022. [DOI: 10.1080/10428194.2022.2131424] [Reference Citation Analysis]
3 Ochoa-grullón J, Guevara-hoyer K, Pérez López C, Pérez de Diego R, Peña Cortijo A, Polo M, Mateo Morales M, Anguita Mandley E, Jiménez García C, Bolaños E, Íñigo B, Medina F, Rodríguez de la Peña A, Izquierdo Delgado C, de la Fuente Muñoz E, Mayol E, Fernández-arquero M, González-fernández A, Benavente Cuesta C, Sánchez-ramón S. Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression. Biomedicines 2022;10:2020. [DOI: 10.3390/biomedicines10082020] [Reference Citation Analysis]
4 Tsilingiris D, Nasiri-ansari N, Spyrou N, Magkos F, Dalamaga M. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges. Cancers 2022;14:2494. [DOI: 10.3390/cancers14102494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Scarpa R, Dell'Edera A, Felice C, Buso R, Muscianisi F, Finco Gambier R, Toffolo S, Grossi U, Giobbia M, Barberio G, Landini N, Facchini C, Agostini C, Rattazzi M, Cinetto F. Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study. Front Immunol 2022;13:842643. [PMID: 35359947 DOI: 10.3389/fimmu.2022.842643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Henze L, Buhl C, Sandherr M, Cornely OA, Heinz WJ, Khodamoradi Y, Kiderlen TR, Koehler P, Seidler A, Sprute R, Schmidt-hieber M, von Lilienfeld-toal M. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Ann Hematol. [DOI: 10.1007/s00277-021-04746-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Allegra A, Tonacci A, Musolino C, Pioggia G, Gangemi S. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Front Immunol 2021;12:738915. [PMID: 34759921 DOI: 10.3389/fimmu.2021.738915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Mustafa SS, Jamshed S, Vadamalai K, Ramsey A. Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia. PLoS One 2021;16:e0258529. [PMID: 34653210 DOI: 10.1371/journal.pone.0258529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Tragiannidis A, Groll AH. Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies. Paediatr Drugs 2021;23:445-55. [PMID: 34292515 DOI: 10.1007/s40272-021-00461-3] [Reference Citation Analysis]
10 Colado A, Elías EE, Sarapura Martínez VJ, Cordini G, Morande P, Bezares F, Giordano M, Gamberale R, Borge M. Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia. Sci Rep 2021;11:12926. [PMID: 34155276 DOI: 10.1038/s41598-021-92412-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ochoa-Grullón J, Peña Cortijo A, Guevara-Hoyer K, Jiménez García C, de la Fuente E, de la Peña AR, Fernández-Arquero M, González Fernández A, Sánchez-Ramón S. B-cell haematological malignancies and SARS-CoV-2 infection: Could immunological interventions influence the outcome? EJHaem 2021. [PMID: 34518828 DOI: 10.1002/jha2.249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Aapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascón P, Kuderer NM. Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open 2021;6:100038. [PMID: 33421735 DOI: 10.1016/j.esmoop.2020.100038] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
13 Monleón Bonet C, Waser N, Cheng K, Tzivelekis S, Edgar JDM, Sánchez-Ramón S. A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants. Expert Rev Clin Immunol 2020;16:911-21. [PMID: 32783541 DOI: 10.1080/1744666X.2020.1807328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lomas OC, Mouhieddine TH, Tahri S, Ghobrial IM. Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All. Cancers (Basel). 2020;12. [PMID: 32545521 DOI: 10.3390/cancers12061554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
15 Ochoa-Grullón J, Benavente Cuesta C, Pérez López C, Peña Cortijo A, Rodríguez de la Peña A, Álvarez Carmona A, Mateo Morales M, Llano-Hernández K, Williams LJ, Rodríguez de Frías E, Guevara-Hoyer K, Cordero Torres G, Orte C, Fernández-Arquero M, Fernández-Paredes L, Serrano-García I, Recio MJ, Pérez de Diego R, Martínez R, Sánchez-Ramón S. Evaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological Malignancies. Clin Immunol 2020;210:108307. [PMID: 31760095 DOI: 10.1016/j.clim.2019.108307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sánchez-Ramón S, Bermúdez A, González-Granado LI, Rodríguez-Gallego C, Sastre A, Soler-Palacín P; ID-Signal Onco-Haematology Group. Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. Front Immunol 2019;10:586. [PMID: 30984175 DOI: 10.3389/fimmu.2019.00586] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
17 Na IK, Buckland M, Agostini C, Edgar JDM, Friman V, Michallet M, Sánchez-Ramón S, Scheibenbogen C, Quinti I. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies. Eur J Haematol 2019;102:447-56. [PMID: 30801785 DOI: 10.1111/ejh.13223] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
18 Eichhorst B, Hallek M. Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management of Chronic Lymphocytic Leukemia: The 2018 Update. Hematologic Malignancies 2019. [DOI: 10.1007/978-3-030-11392-6_5] [Reference Citation Analysis]
19 Angelillo P, Capasso A, Ghia P, Scarfò L. Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach? European Journal of Internal Medicine 2018;58:2-6. [DOI: 10.1016/j.ejim.2018.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
20 Strati P, Jain N, O'brien S. Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clinic Proceedings 2018;93:651-64. [DOI: 10.1016/j.mayocp.2018.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
21 Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 2018;131:2745-60. [PMID: 29540348 DOI: 10.1182/blood-2017-09-806398] [Cited by in Crossref: 671] [Cited by in F6Publishing: 718] [Article Influence: 134.2] [Reference Citation Analysis]
22 Kralickova P, Kuhnova J, Soucek O, Vodarek P, Zak P, Simkovic M, Motyckova M, Smolej L, Mala E, Andrys C, Krejsek J, Thon V. Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies. J Immunol Res 2017;2017:7304658. [PMID: 29392143 DOI: 10.1155/2017/7304658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
23 Criado I, Muñoz-Criado S, Rodríguez-Caballero A, Nieto WG, Romero A, Fernández-Navarro P, Alcoceba M, Contreras T, González M, Orfao A, Almeida J; Primary Health Care Group of Salamanca for the Study of MBL. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression. Haematologica 2017;102:1238-46. [PMID: 28385786 DOI: 10.3324/haematol.2016.159012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jolles S, Chapel H, Litzman J. When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach. Clin Exp Immunol. 2017;188:333-341. [PMID: 28000208 DOI: 10.1111/cei.12915] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 12.2] [Reference Citation Analysis]